FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to benzoxazepinoxazolidinones of formula I, pharmaceutical compositions on and base selectively inhibiting PI3Kα mutant form, methods of treating cancer, associated with expression of mutant form PI3Kα.
(I).
EFFECT: obtaining novel compounds suitable for treating cancer associated with expression of mutant form PI3Kα.
23 cl, 21 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITOR CONTAINING A TRICYCLIC DERIVATIVE, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800543C2 |
| MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE-3-KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | 2013 |
|
RU2665949C2 |
| METHOD FOR PREPARATION OF BENZOXAZEPINE COMPOUNDS | 2014 |
|
RU2649976C2 |
| BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
| BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
| POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF | 2014 |
|
RU2658009C2 |
| HETEROAROMATIC COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE MODULATORS AND METHODS OF USE | 2013 |
|
RU2665036C9 |
| HETEROAROMATIC COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE MODULATORS | 2014 |
|
RU2672910C9 |
| 8-ANILINOIMIDAZOPYRIDINES AND METHODS FOR USE THEREOF | 2008 |
|
RU2498985C2 |
| PI3-KINASE INHIBITORS AND USE THEREOF | 2010 |
|
RU2595718C2 |
